Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TEX26-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF85 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WNT10A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEA10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM110A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTTY14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LZTFL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928371 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LRRC74B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD86 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTSS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STPG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRICKLE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RORA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MST1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on